Kymera Therapeutics KYMR
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 77.81 | 112.67 | -0.98 | -97,896 | -87 | |
| 2025Q3 | 56.60 | 112.73 | -0.94 | -92,520 | -82 | |
| 2025Q2 | 43.64 | 110.52 | -0.95 | -84,557 | -77 | |
| 2025Q1 | 27.37 | 113.61 | -0.82 | -74,426 | -66 | |
| 2024Q4 | 40.23 | 114.23 | -0.89 | -80,755 | -71 | |
| 2024Q3 | 47.33 | 115.53 | -0.83 | -72,124 | -62 | |
| 2024Q2 | 29.85 | 121.25 | -0.57 | -50,925 | -42 | |
| 2024Q1 | 40.20 | 119.27 | -0.69 | -57,831 | -49 | |
| 2023Q4 | 25.46 | 134.90 | -0.25 | -19,312 | -14 | |
| 2023Q3 | 13.90 | 108.86 | -0.90 | -57,509 | -53 | |
| 2023Q2 | 22.99 | 111.95 | -0.67 | -43,383 | -39 | |
| 2023Q1 | 29.63 | 110.89 | -0.70 | -45,326 | -41 | |
| 2022Q4 | 24.96 | 110.99 | -0.59 | -38,630 | -35 | |
| 2022Q3 | 21.77 | 104.46 | -0.79 | -44,882 | -43 | |
| 2022Q2 | 19.69 | 101.48 | -0.78 | -40,811 | -40 | |
| 2022Q1 | 42.32 | 100.79 | -0.71 | -36,933 | -37 | |
| 2021Q4 | 63.49 | 100.43 | -0.67 | -33,994 | -34 | |
| 2021Q3 | 58.74 | 100.44 | -0.58 | -28,637 | -29 | |
| 2021Q2 | 48.50 | 100.40 | -0.55 | -24,730 | -25 | |
| 2021Q1 | 38.86 | 100.90 | -0.29 | -13,169 | -13 |